XENOGESIS LIMITED
XENOGESIS LIMITED is a private limited company registered in the United Kingdom, under 07541784, incorporated on 24 February 2011. The company is currently active. Operates in the dormant company sector (SIC 99999). The company has been operating for 15 years. Registered office address: NG1 1GR Nottingham, the United Kingdom. Formerly known as FULLY INTEGRATED PHARMA SOLUTIONS LIMITED. Directors include MR JAMES FENWICK EDGAR, MR KIERON ASHLEY HALL, and MR SIMON CHRISTOPHER HIRST, and 1 other. Sole shareholder is SYGNATURE DISCOVERY LIMITED. Associated with 20 related entities, including SB DRUG DISCOVERY LIMITED, SPARK TOPCO LIMITED, and SPARK PIKCO LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
FULLY INTEGRATED PHARMA SOLUTIONS LIMITED
Registered Address
DISCOVERY BUILDING BIOCITY
PENNYFOOT STREET
NG1 1GR NOTTINGHAM
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (2)
| Date | Change | Details |
|---|---|---|
| 2026-04-16 | DIRECTOR ADDED | Kieron Ashley Hall (director) |
| 2026-04-16 | DIRECTOR ADDED | James Fenwick Edgar (director) |
Source Records (1)
| companieshouse | 07541784 | 2026-06-01 | open_in_new |